Nuvalent (NUVL) Tax Provisions (2024 - 2026)
Nuvalent's (NUVL) quarterly Tax Provisions came in at $168000.0 in Q1 2026, up 7.01% YoY from $157000.0 in Q1 2025, and up 100.19% on a QoQ basis from -$89.6 million in Q4 2025.
Analysis
Nuvalent (NUVL) Tax Provisions (2024 - 2026) Analysis & Trends
Nuvalent (NUVL) has 3 years of Tax Provisions data on file, last reported at $168000.0 in Q1 2026.
- Quarterly Tax Provisions rose 7.01% year-over-year to $168000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$89.2 million (down 16679.0% YoY) and the FY2025 annual result came in at -$89.2 million, down 11776.18% from the prior year.
- Tax Provisions rose to $168000.0 in Q1 2026, from -$89.6 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $383000.0 in Q1 2024 to a low of -$89.6 million in Q4 2025.
- A 3-year average of -$9.8 million and a median of $157000.0 in 2025 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 230.0% in 2025, down 52521.05% in 2025.
- Tracing NUVL's Tax Provisions over 3 years: stood at $171000.0 in 2024, then sank by 52521.05% to -$89.6 million in 2025, then jumped by 100.19% to $168000.0 in 2026.
- The last three Tax Provisions figures came in at $168000.0 (Q1 2026), -$89.6 million (Q4 2025), and $132000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | 168,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 168,000.00 |
| Dec 31, 2025 | -89.64 Mn |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 145,000.00 |
| Mar 31, 2025 | 157,000.00 |
| Dec 31, 2024 | 207,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 170,000.00 |
| Mar 31, 2024 | 383,000.00 |